Drug Shortage Report for ONCASPAR
| Report ID | 241135 |
| Drug Identification Number | 02461900 |
| Brand name | ONCASPAR |
| Common or Proper name | Pegaspargase injection |
| Company Name | SERVIER CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PEGASPARGASE |
| Strength(s) | 750UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 5 ml |
| ATC code | L01XX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-01-06 |
| Actual start date | |
| Estimated end date | 2025-05-31 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-11-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3224 AVENUE JEAN-BÉRAUD LAVAL, QUEBEC CANADA H7T 2S4 |
| Company contact information | Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4 Phone : (450) 978-9700 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-11-28 | French | Compare |
| v5 | 2024-11-28 | English | Compare |
| v4 | 2024-11-04 | French | Compare |
| v3 | 2024-11-04 | English | Compare |
| v2 | 2024-10-25 | French | Compare |
| v1 | 2024-10-25 | English | Compare |
Showing 1 to 6 of 6